Cargando…

Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden

OBJECTIVE: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a rare, progressive and fatal condition caused by deposition of transthyretin amyloid fibrils in the heart. This study aims to identify all patients diagnosed with ATTR-CM in Sweden, estimate the prevalence of ATTR-CM, describe patient cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lauppe, Rosa Elisabeth, Liseth Hansen, Johan, Gerdesköld, Christian, Rozenbaum, Mark H, Strand, Anne Mette, Vakevainen, Merja, Kuusisto, Johanna, Gude, Einar, Gustafsson, Finn, Smith, J Gustav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Heart Failure and Cardiomyopathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515473/ https://www.ncbi.nlm.nih.gov/pubmed/34645699 http://dx.doi.org/10.1136/openhrt-2021-001755

Ejemplares similares

Healthcare resource use of patients with transthyretin amyloid cardiomyopathy
por: Lauppe, Rosa, et al.
Publicado: (2022)

Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries
por: Lauppe, Rosa, et al.
Publicado: (2022)

US CARDIOLOGIST AND PATIENT PERSPECTIVES ON COVID-19 TELEHEALTH PRACTICES FOR PATIENTS WITH TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM)
por: Mitter, Sumeet, et al.
Publicado: (2021)

Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy
por: Law, Steven, et al.
Publicado: (2022)

Cardiomyopathy associated with the Ala143Thr variant of the α-galactosidase A gene
por: Valtola, Kati, et al.
Publicado: (2020)

Results of comprehensive diagnostic work-up in ‘idiopathic’ dilated cardiomyopathy
por: Broch, Kaspar, et al.
Publicado: (2015)

Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy
por: Javidgonbadi, Davood, et al.
Publicado: (2019)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

Uric acid in advanced heart failure: relation to central haemodynamics and outcome
por: Deis, Tania, et al.
Publicado: (2022)

Exercise and myocardial injury in hypertrophic cardiomyopathy
por: Cramer, G Etienne, et al.
Publicado: (2020)

Copper chelation in patients with hypertrophic cardiomyopathy
por: Reid, Anna, et al.
Publicado: (2022)

Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden
por: Rossides, Marios, et al.
Publicado: (2022)

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy
por: Ho, Jennifer E, et al.
Publicado: (2017)

Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathy
por: Graziosi, Maddalena, et al.
Publicado: (2022)

Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy
por: Damy, Thibaud, et al.
Publicado: (2016)

Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity
por: de Feria, Alejandro E, et al.
Publicado: (2021)

Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy
por: Hammersley, Daniel J, et al.
Publicado: (2022)

Repetitive squatting exercise as a diagnostic predictor in patients with dilated cardiomyopathy
por: Sveric, Krunoslav Michael, et al.
Publicado: (2018)

Systematic review and meta-analysis of prolactin and iron deficiency in peripartum cardiomyopathy
por: Cherubin, Sinaida, et al.
Publicado: (2020)

Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy
por: Camaioni, Claudia, et al.
Publicado: (2020)

Aetiological and morphological spectrum of cardiomyopathies in French Guiana: a retrospective study
por: Leménager, Paul, et al.
Publicado: (2020)

Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy
por: Salazar-Mendiguchía, Joel, et al.
Publicado: (2020)

Association between right ventricular strain and outcomes in patients with dilated cardiomyopathy
por: Liu, Tong, et al.
Publicado: (2021)

Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2022)

Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy
por: Tateishi, Emi, et al.
Publicado: (2015)

Stress-coping skills and neuroticism in apical ballooning syndrome (Takotsubo/stress cardiomyopathy)
por: Scantlebury, Dawn C, et al.
Publicado: (2016)

Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy
por: Gastl, Mareike, et al.
Publicado: (2020)

Clinical profile and prognostic factors of alcoholic cardiomyopathy in tribal and non-tribal population
por: Dungdung, Ajit, et al.
Publicado: (2020)

ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathy
por: Grall, Sylvain, et al.
Publicado: (2014)

The influence of aortoseptal angulation on provocable left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
por: Critoph, Christopher Howell, et al.
Publicado: (2014)

Novel genotype–phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy
por: Lopes, Luis R, et al.
Publicado: (2015)

Demographic features and prevalence of myocarditis in patients undergoing transarterial endomyocardial biopsy for unexplained cardiomyopathy
por: Hassan, Ayman K.M., et al.
Publicado: (2017)

Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy
por: Fan, Peng, et al.
Publicado: (2021)

CMR feature tracking in patients with dilated cardiomyopathy: patterns of myocardial strain and focal fibrosis
por: Chevalier, Céleste, et al.
Publicado: (2022)

Health‐related quality of life among transthyretin amyloid cardiomyopathy patients
por: Eldhagen, Per, et al.
Publicado: (2023)

Characteristics and outcome of patients with COVID-19 complicated by Takotsubo cardiomyopathy: case series with literature review
por: Hegde, Shruti, et al.
Publicado: (2020)

Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
por: Adalsteinsdottir, Berglind, et al.
Publicado: (2020)

Association of early versus delayed normalisation of left ventricular ejection fraction with mortality in ischemic cardiomyopathy
por: Schiffer, Walter B, et al.
Publicado: (2021)

FOXO3A acts as immune response modulator in human virus-negative inflammatory cardiomyopathy
por: Makrutzki-Zlotek, Kamila, et al.
Publicado: (2023)

Late-onset and classic phenotypes of Fabry disease in males with the GLA-Thr410Ala mutation
por: Valtola, Kati, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_73kn8c50gkkl394i69uofei9sh